The retail giant will sell the Dexcom G7 continuous glucose monitoring system to eligible customers through a new online platform.
Best Buy, which bills itself as the world’s largest specialty consumer electronics retailer, will soon sell DexCom’s G7 continuous glucose monitor (CGM). It is the first prescription-based medical device Best Buy has ever sold.
Dexcom’s G7 will "soon" be available to eligible customers on a new online platform, Wellness.BestBuyHealth.com, Best Buy announced on 9 October.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
